Sofía Bernal Silva

Búsqueda avanzada

Contacto:

gci@uaslp.mx

Búsqueda Investigador

Perfil del investigador

Sofía Bernal Silva

Datos personales:

Grado Académico: Doctorado

Nivel SNI: I

ORBIS ID: n70099

Datos Institucionales:

Entidad Académica: Facultad de Medicina

Dirección de oficina: Av. Venustiano Carranza 2405 Los Filtros CP. 78210 San Luis Potosí

Teléfono: (+52) 4448262300

Ext.: 6656

Correo electrónico: sofia.bernal@uaslp.mx

Doctorado en Ciencias con orientación en Biología Molecular e Ingeniería Genética
Universidad Autónoma de Nuevo León
Maestría en Ciencias con Especialidad en Biología Molecular e Ingeniería Genética
Universidad Autónoma de Nuevo León
Licenciatura en Médico Cirujano
Universidad Autónoma de San Luis Potosí

Intereses del grupo de investigación

Epidemiología Molecular
Infecciones Virales y Sistema Inmune

Article
- Incidence of congenital and postnatal cytomegalovirus infection during the first year of life in Mexican preterm infants. Journal of Medical Virology. 94:3349-3358. 2022-01-01
- Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis. Journal of Immunology Research. 2022:-. 2022-01-01
- Peripheral Blood Mitochondrial DNA Levels Were Modulated by SARS-CoV-2 Infection Severity and Its Lessening Was Associated With Mortality Among Hospitalized Patients With COVID-19. Frontiers in Cellular and Infection Microbiology. 11:-. 2021-01-01
- Phylogenomics and population genomics of sars-cov-2 in mexico during the pre-vaccination stage reveals variants of interest b.1.1.28.4 and b.1.1.222 or b.1.1.519 and the nucleocapsid mutation s194l associated with symptoms. Microbial Genomics. 7:-. 2021-01-01
- Respiratory syncytial virus B sequence analysis reveals a novel early genotype. Scientific Reports. 11:-. 2021-01-01
Chapter
- Global epidemiology and impact of the SARS-CoV-2 pandemic. Mathematical Modelling, Simulations, and AI for Emergent Pandemic Diseases. 7-42. 2023-01-01
- Introduction to the SARS-CoV-2/COVID-19 epidemiology. Biomedical Innovations to Combat COVID-19. 53-64. 2022-01-01